Complement Inhibitors – Eculizumab and Ravulizumab-cwvz | Commonwealth Care Alliance

Skip to main content ↓

Home
Contact Us

Enroll in a CCA Health plan. Contact us →

Select Your State

A Decrease font size. A Reset font size. A Increase font size.

Home
Contact Us

Select Your State

A Decrease font size. A Reset font size. A Increase font size.

Home › Documents › Complement Inhibitors – Eculizumab and Ravulizumab-cwvz

Complement Inhibitors – Eculizumab and Ravulizumab-cwvz

view:

PDF | Updated 3-13-24

Facebook
Twitter
LinkedIn
YouTube
Instagram

About Us

Our Approach to Care
Our Health Plans
Partnership Solutions

Innovation
Newsroom & Publications
Careers

CCA Plans

CCA Massachusetts
CCA Health Rhode Island
CCA Health Michigan
CCA Health California

CCA Websites

CCA Primary Care
instED®
Winter Street Ventures®
Center to Advance Consumer Partnership

Contact Us

Corporate Office:

30 Winter Street

Boston, MA 02108

View Linked Article: Best Place to Work for Disability Inclusion 2024 logo

Get assistance in your language:

If you speak a language other than English, language assistance services are available to you free of charge. To get an interpreter, visit Language Assistance.

Accessibility
Interoperability
Privacy Policy
Terms of Use

HIPAA Notice of Privacy Practices
Notice of Nondiscrimination
Appeals & Grievances
Compliance
Disclaimers

Last updated: 03/13/24

© 2024 Commonwealth Care Alliance, Inc.